Evidence map›Paper›PMID 39257027›Full record

ArticleMicrobial biotechnology2024

Contribution of machine learning for subspecies identification from Mycobacterium abscessus with MALDI-TOF MS in solid and liquid media.

Alexandre Godmer, Lise Bigey, Quentin Giai-Gianetto, Gautier Pierrat, Noshine Mohammad, Faiza Mougari, Renaud Piarroux, Nicolas Veziris, Alexandra Aubry

Abstract readEvaluation Study
In one paragraph

Article in Microbial biotechnology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Enhanced identification ofJournal of mass spectrometry and advances in the clinical lab · 2025
    Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Alexandre GodmerU1135, Centre d'Immunologie et des Maladies Infectieuses (Cimi-Paris), Sorbonne Université, Paris, France.ORCID 0000-0002-5211-5796
Lise BigeyU1135, Centre d'Immunologie et des Maladies Infectieuses (Cimi-Paris), Sorbonne Université, Paris, France.
Quentin Giai-GianettoInstitut Pasteur, Université Paris Cité, Bioinformatics and Biostatistics HUB, Paris, France.
Gautier PierratAP-HP, Sorbonne Université (Assistance Publique Hôpitaux de Paris), Département de Bactériologie, Groupe Hospitalier Universitaire, Sorbonne Université, Hôpital, Paris, France.
Noshine MohammadInserm, Institut Pierre-Louis d'Epidémiologie et de Santé Publique, IPLESP, AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Service de Parasitologie- Mycologie, Sorbonne Université, Paris, France.ORCID 0000-0002-3891-0216
Faiza MougariService de Mycobactériologie spécialisée et de référence, Centre National de Référence des Mycobactéries (Laboratoire associé), APHP GHU Nord, Université Paris Cité, INSERM IAME UMR, Paris, France.
Renaud PiarrouxInserm, Institut Pierre-Louis d'Epidémiologie et de Santé Publique, IPLESP, AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Service de Parasitologie- Mycologie, Sorbonne Université, Paris, France.
Nicolas VezirisU1135, Centre d'Immunologie et des Maladies Infectieuses (Cimi-Paris), Sorbonne Université, Paris, France.
Alexandra AubryU1135, Centre d'Immunologie et des Maladies Infectieuses (Cimi-Paris), Sorbonne Université, Paris, France.

Funding

Annual grant from National Public Health Agency (Santé Publique France)
6 · The paper itself

Abstract

Mycobacterium abscessus (MABS) displays differential subspecies susceptibility to macrolides. Thus, identifying MABS's subspecies (M. abscessus, M. bolletii and M. massiliense) is a clinical necessity for guiding treatment decisions. We aimed to assess the potential of Machine Learning (ML)-based classifiers coupled to Matrix-Assisted Laser Desorption/Ionization Time-of-Flight (MALDI-TOF) MS to identify MABS subspecies. Two spectral databases were created by using 40 confirmed MABS strains. Spectra were obtained by using MALDI-TOF MS from strains cultivated on solid (Columbia Blood Agar, CBA) or liquid (MGIT®) media for 1 to 13 days. Each database was divided into a dataset for ML-based pipeline development and a dataset to assess the performance. An in-house programme was developed to identify discriminant peaks specific to each subspecies. The peak-based approach successfully distinguished M. massiliense from the other subspecies for strains grown on CBA. The ML approach achieved 100% accuracy for subspecies identification on CBA, falling to 77.5% on MGIT®. This study validates the usefulness of ML, in particular the Random Forest algorithm, to discriminate MABS subspecies by MALDI-TOF MS. However, identification in MGIT®, a medium largely used in mycobacteriology laboratories, is not yet reliable and should be a development priority.

Indexed as

Culture MediaMachine LearningMycobacterium abscessusSpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationHumansMycobacterium Infections, NontuberculousCulture Media

Identifiers

PMID39257027
PMCPMC11387462

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.